Oncotype DX testing and differences in use of chemotherapy by age in an integrated system

被引：0
|
作者：
Aller, Ashley
Lyon, Liisa
Habel, Laurel
Shirazi, Aida
Liu, Raymond
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3822
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3822
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Patterns of oncotype DX testing and adjuvant chemotherapy use in a tertiary care centre
    Sudan, Gautam
    Mates, Mihaela
    Wilma, Hopman
    CANCER RESEARCH, 2015, 75
  • [2] Impact of Oncotype-DX testing on choice of chemotherapy.
    Yip, Walter
    Dobosz, Krzysztof
    Illmann, Caroline
    Willemsma, Kaylie
    Simmons, Christine E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Relationship between Oncotype DX testing and the use of chemotherapy in high-risk patients (pts).
    Wong, Winston
    Cooper, Joseph
    Richardson, Steve
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Evaluation of variables that may impact the use of Oncotype DX testing
    Szabo, Stephen
    Gilmore, James W.
    Haislip, Sally
    Hassell, Robert
    Cooper, Joseph
    Richardson, Steve
    Fitzgerald, Meghan
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Age disparity in Oncotype DX testing in a community oncology setting.
    Khajuria, Suheir
    Adams, Ashley
    Schreiber, Andrew Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [6] Oncotype Dx use and its relationship with chemotherapy administration in the general population
    Chavez-MacGregor, Mariana
    Niu, Jiangong
    Smith, Benjamin
    Zhao, Hui
    Buchholz, Thomas A.
    Giordano, Sharon H.
    CANCER RESEARCH, 2015, 75
  • [7] Stretching the boundary of Oncotype DX testing
    Al-Saheli, Zaid
    Dabak, Vrushali
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Benefits of introduction of Oncotype DX® testing
    Green, N.
    Al-Allak, A.
    Fowler, C.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2019, 101 (01) : 55 - 59
  • [9] The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment
    Iles, Kathleen
    Roberson, Mya L.
    Spanheimer, Philip
    Gallagher, Kristalyn
    Ollila, David W.
    Strassle, Paula D.
    Downs-Canner, Stephanie
    NPJ BREAST CANCER, 2022, 8 (01)
  • [10] The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment
    Kathleen Iles
    Mya L. Roberson
    Philip Spanheimer
    Kristalyn Gallagher
    David W. Ollila
    Paula D. Strassle
    Stephanie Downs-Canner
    npj Breast Cancer, 8
12345